Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program

OBJECTIVE: This study assessed the incidence of serious adverse events of diabetic ketoacidosis (DKA) among patients with type 2 diabetes treated with canagliflozin. RESEARCH DESIGN AND METHODS: All serious adverse events of DKA and related events (ketoacidosis, metabolic acidosis, and acidosis) fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Erondu, Ngozi, Desai, Mehul, Ways, Kirk, Meininger, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542268/
https://www.ncbi.nlm.nih.gov/pubmed/26203064
http://dx.doi.org/10.2337/dc15-1251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542268/
https://www.ncbi.nlm.nih.gov/pubmed/26203064
http://dx.doi.org/10.2337/dc15-1251

Ejemplares similares